Lb Pharmaceuticals LBRX
NASDAQ LBRX
$39.42 +0.19 (+0.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Short-term Investments (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported Short-term Investments of $44.68 million for Q2 2026, down 0.6% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals posted Short-term Investments of $45.04 million, up 797.0% from FY2024.

  • By year, Short-term Investments came in at $5.02 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Short-term Investments since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $44.96 million (Q1 2026), $45.04 million (Q4 2025) and $44.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Lb Pharmaceuticals 1.13 Bn -172.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.68 Mn
Mar 31, 2026 44.96 Mn
Dec 31, 2025 45.04 Mn
Sep 30, 2025 44.74 Mn
Dec 31, 2024 5.02 Mn
API Access

Lb Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=LBRX&period=max&api_key=YOUR_API_KEY